Form 4: Director Winston Kung Receives Janux Therapeutics Equity

Janux Therapeutics director Winston Kung was granted 5,500 restricted stock units and 15,500 stock options on June 11, 2026.

Summary

• Director Winston Kung acquired 5,500 restricted stock units (RSUs) as part of a compensation grant.
• Director Winston Kung was granted 15,500 stock options with an exercise price of $13.66 per share.
• The RSUs vest on the earlier of June 11, 2027, or the date of the next annual stockholder meeting.
• The stock options vest in equal monthly installments over 12 months, fully vesting by the next annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral for the stock price.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Issuance of equity results in potential future dilution for existing shareholders.

Risks

• Continued service requirements for vesting create dependency on director retention.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director compensation.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard practice in the biotechnology sector to incentivize board members and align their interests with the company's long-term clinical and commercial success.

Comparison to Industry Standards

• The use of RSU and option-based compensation is consistent with standard corporate governance practices for mid-cap biotechnology firms.
• Vesting schedules tied to annual meetings are common for non-employee directors in the industry.

Stakeholder Impact

• Minor dilution impact on existing shareholders due to the issuance of new equity.

Next Steps

• Vesting of RSUs on June 11, 2027 or the next annual meeting.
• Monthly vesting of stock options over the next 12 months.

Key Dates

Keywords

Janux Therapeutics, JANX, Form 4, Insider Trading, Equity Compensation, Director Compensation